• Home
  • The Quivive Team
  • For Investors
  • News & Events
  • More
    • Home
    • The Quivive Team
    • For Investors
    • News & Events
  • Home
  • The Quivive Team
  • For Investors
  • News & Events

News and EVENTS

Quivive Partners with Camargo Pharmaceutical Services

PRESS RELEASE  Quivive Pharma Partners with Camargo Pharmaceutical Services for Development Programs 

Quivive Pharma Granted First US-PTO Patent

On July  3, 2018, US Patent  No. 10,004,479 was allowed for the the combination of an opioid and a respiratory stimulant


Copyright © 2022 Quivive Pharma, inc - All Rights Reserved.